Invests in iLoF

2024/10/24

As the healthcare industry moves towards personalized medicine, a major challenge has been the lack of efficient tools for non-invasive, AI-powered analysis of biological profiles. iLoF is addressing this gap with their proprietary Optomics® platform, which uses advanced photonics and AI to accelerate early detection and patient stratification, enabling more precise diagnostic and therapeutic pathways. 

 

https://ilof.tech/

Contact us to learn more about CVC.